80岁以上老年口腔鳞癌患者动脉灌注化疗同步放疗的临床结局
这项回顾性观察研究纳入31例80岁以上口腔鳞癌患者,接受动脉灌注多西他赛联合顺铂同步放疗(60 Gy/6周),中位随访37个月,3年总生存率78%、局部区域控制率81%,主要急性3级不良事件为口腔黏膜炎(71%)、中性粒细胞减少(52%)和皮炎(35%),未观察到4级及以上毒性。
要点
- 80岁以上口腔鳞癌患者行动脉灌注化疗同步放疗,3年总生存率78%、局部区域控制率81%。
- 主要急性3级不良事件为口腔黏膜炎71%、中性粒细胞减少52%、皮炎35%。
- 晚期3级放射性颌骨坏死仅1例(3%),治疗及随访期间无4级及以上毒性。
核心结论
- 动脉灌注化疗同步放疗可改善老年口腔鳞癌患者的总生存和局部区域控制。
研究设计与样本
- 回顾性观察研究纳入31例80岁以上口腔鳞癌患者,治疗方案为动脉灌注多西他赛(总60 mg/m2)联合顺铂(总150 mg/m2)同步每日放疗(总60 Gy)共6周。
主要发现
- 患者中位年龄82.5岁(范围80-88岁),II期6例(19%)、III期6例(19%)、IVA期17例(55%)、IVB期2例(6%)。
- 全部患者中位随访37个月(范围7-86个月),3年总生存率为78%,3年局部区域控制率为81%。
- 主要急性3级不良事件为口腔黏膜炎22例(71%)、中性粒细胞减少16例(52%)、皮炎11例(35%)。
- 晚期毒性中1例(3%)发生3级放射性颌骨坏死,治疗及随访期间未观察到4级及以上毒性。
临床怎么用
- 对80岁以上口腔鳞癌患者,可考虑动脉灌注多西他赛联合顺铂同步60 Gy放疗,但需密切监测口腔黏膜炎和中性粒细胞减少。
局限性
- 本研究为回顾性观察研究,样本量仅31例,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this retrospective observational study was to evaluate toxicities, overall survival, and locoregional control in elderly oral squamous cell carcinoma patients who had undergone retrograde intra-arterial chemotherapy combined with radiotherapy. METHODS: Thirty-one elderly patients over 80 years old with oral squamous cell carcinoma were enrolled in present study. The treatment schedule consisted of intra- arterial chemotherapy (docetaxel, total 60 mg/m2; cisplatin, total 150 mg/m2) and daily concurrent radiotherapy (total, 60 Gy) for 6 weeks. RESULTS: The median patient age was 82.5 years old (range, 80-88 years). Of the 31 patients, six (19%) had stage II, 6 (19%) had stage III, 17 (55%) had stage IVA, and 2 (6%) had stage IVB. The median follow-up period for all patients was 37 months (range, 7-86 months). The 3-year overall survival and locoregional control rates were 78% and 81%, respectively. The major acute grade 3 adverse events were oral mucositis in 22 (71%) patients, neutropenia in 16 (52%), and dermatitis in 11 (35%). With respect to late toxicities, 1 patient (3%) developed grade 3 osteoradionecrosis of the jaw. No grade 4 or higher toxicities were observed during the treatment and follow-up periods. CONCLUSIONS: Retrograde intra-arterial chemotherapy combined with radiotherapy was effective in improving overall survival and locoregional control even for elderly patients.
引用
- Hayashi Y, Mitsudo K, Sakuma K, et al. Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years old. Radiat Oncol. 2017. PMID: 28673362. doi:10.1186/s13014-017-0847-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。